check_circleStudy Completed

Erectile Dysfunction

BAY38-9456 ERprototypes enteric-coated and GITS

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

18 - 50 Years
  • -

  • -

Trial summary

Enrollment Goal
15
Trial Dates
October 2007 - January 2008
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Vardenafil ER (BAY38-9456)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
Bayer HealthCareWuppertal, 42096, Germany

Trial design

Randomized study in a 5-fold crossover, single-dose design to investigate the pharmacokinetics of two 20 mg vardenafil extended release tablet formulations in the fed and fasted condition, respectively, in comparison to a 20 mg standard Levitra® tablet in healthy male subjects.
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A